Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 17, 1999

View Archived Issues

PowderJect, Ares-Serono Enter $100M Deal For Dry Vaccines

British Biotech's Marimastat Fails In Pivotal Cancer Study

Genetically Modified Milk Could Be Next On Shelves

Biota's Influenza Drug Wins Pair Of Approvals

Genset Reports Highest Quarterly Loss Of Year

European Parliament Calls For Amended GMO Rules

Cerep Revenues Hit Slump After Several Contracts End

EU Backs Biosafety Protocol, Warns Of 'Extreme Positions'

GMO Soya Crops Will Outdo Other Variety, Says Professor

Trinity Biotech's EPS Up 67 Percent For Year

Virax Shares Valued Higher After Patents

Monsanto's GMO Cotton Plan Still Stymied By EU

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...